{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-101393","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2024-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.958819+00:00","generated_at":"2026-05-31T03:38:06.438845+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Rhythm Pharma shareholders elect three directors, approve equity plan at annual meeting","bullets":["Elected Class I directors: Stuart Arbuckle (45.6M for), Christophe Jean (45.0M), Lynn Tetrault (45.5M).","Ratified Ernst & Young as auditor: 53.8M for, 69.5K against.","Advisory vote on executive compensation: 50.6M for, 1.5M against.","Reapproved 2017 Equity Incentive Plan: 32.7M for, 19.4M against (63% of votes cast)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-101393","json":"https://secwatch.observer/filing/0001104659-24-101393.json","markdown":"https://secwatch.observer/filing/0001104659-24-101393.md","text":"https://secwatch.observer/filing/0001104659-24-101393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924101393/0001104659-24-101393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924101393/tm2424430d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:38:06.438845+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}